03/30/2026 | Press release | Distributed by Public on 03/30/2026 19:23
Visit Highlights Pennsylvania's Role as a Leader in Life Sciences
PITTSBURGH, PA - U.S. Senator Dave McCormick (R-PA) today hosted National Institutes of Health (NIH) Director Dr. Jay Bhattacharya for a full-day visit to Pittsburgh, where they toured some of the nation's leading life sciences and research institutions. The visit highlighted how federal research investment translates into jobs, medical breakthroughs, and economic growth and why Pennsylvania continues to be a productive partner in biomedical innovation.
"Pennsylvania is one of the great life sciences hubs in the world, and I was proud to welcome Director Bhattacharya to Pittsburgh to see it firsthand," said Senator McCormick. "What's happening here is extraordinary - treatment centers where discoveries are being made, researchers dedicated to finding answers, and families whose lives have been changed. That is accountability you can see. With advances in artificial intelligence and new technologies accelerating research, Pennsylvania is well positioned to lead the next generation of medical innovation."
"I am truly honored to spend the day in Pittsburgh, a city that exemplifies what reinvention can look like at its best. Once defined by its steel industry, Pittsburgh has transformed itself into a thriving center for biotechnology and innovation which is a remarkable evolution. What stands out most is the extraordinary collaboration among the University of Pittsburgh, UPMC, and Carnegie Mellon University. Together, they represent a powerful trifecta of research and innovation, seamlessly bridging cutting-edge technology with biomedical discovery in ways that set a standard for institutions across the country. Pennsylvania's emergence as a leader in this space underscores the profound impact of sustained NIH investment in research institutions beyond the coasts. The breakthroughs happening here are not only advancing science, but improving human health in meaningful and far-reaching ways, said NIH Director Dr. Jay Bhattacharya.
Throughout the visit, Senator McCormick convened researchers, clinicians, philanthropists, investors, business leaders, and university executives from across the Pittsburgh region to highlight the impact of NIH-supported research and the strength of Pennsylvania's life sciences ecosystem.
At the UPMC Vision Institute, Senator McCormick and Dr. Bhattacharya observed research moving rapidly from the laboratory into clinical practice, with advances in the diagnosis and treatment of eye disease offering new hope to patients at risk of losing their sight. At the UPMC Rehabilitation Institute, they witnessed the direct impact of federally supported care on patients recovering from strokes, spinal cord injuries, traumatic brain injuries, and limb loss.
They also visited the UPMC Hillman Cancer Center -one of only 57 Comprehensive Cancer Centers across the country and the only NCI-designated Comprehensive Cancer Center in western Pennsylvania - they met researchers advancing new cancer treatments and prevention, bringing that work to patients in rural communities across the region. The day culminated with Senator McCormick and Director Bhattacharya leading a Life Sciences Industry Symposium, where they met with business leaders, university executives, hospital administrators, philanthropists, and investors from across the Pittsburgh region and discussed how NIH funding is driving commercialization and growth in the biotechnology sector.
Pennsylvania ranks as the fourth largest recipient of NIH funding in the nation, receiving $2.27 billion in federal research funding in FY 2025. The University of Pittsburgh and UPMC alone received $670 million, ranking ninth nationally. Statewide, NIH investment supports more than 21,000 research jobs and generates $5.31 billion in annual economic activity.
NIH-driven commercialization has also helped launch thousands of businesses and nearly 100,000 biopharmaceutical jobs across the Commonwealth. For every dollar of NIH funding, $2.56 flows back into the economy - a strong and consistent return for American taxpayers.
###